Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective Date 1st September 2025
Solactive China Healthcare Disruption Index:
In the ordinary adjustment, the following composition was implemented effective open 1st September 2025:
| HUTCHMED CHINA LTD | 0.24% |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 5.33% |
| SIHUAN PHARMACEUTICAL HLDGS GRP ORD | 0.14% |
| GRAND PHARMACEUTICAL GROUP LTD | 0.32% |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.04% |
| CSPC PHARMACEUTICAL GROUP LTD | 7.83% |
| JACOBIO PHARMACEUTICALS GROUP CO LTD | 0.07% |
| SINO BIOPHARMACEUTICAL LTD ORD | 8.00% |
| HENGRUI PHARMA ORD H | 8.00% |
| SHANGHAI FUDAN-ZHANGJIANG BIO- | 0.10% |
| LIVZON PHARMACEUTICAL GROUP INC | 2.31% |
| IMMUNEONCO-B ORD H | 0.06% |
| GENSCRIPT BIOTECH CORP | 2.40% |
| ASCLETIS PHARMA INC | 1.07% |
| INNOVENT BIOLOGICS INC | 8.00% |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 2.68% |
| EVEREST MEDICINES LTD | 0.27% |
| SIMCERE PHARMACEUTICAL GROUP | 0.33% |
| HBM HOLDINGS LTD | 0.11% |
| LEPU BIOPHARMA CO LTD-H | 0.19% |
| KEYMED BIOSCIENCES INC | 0.24% |
| LUYE PHARMA GROUP LTD | 0.16% |
| MEDLIVE TECHNOLOGY CO LTD | 0.12% |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 4.82% |
| JINHAI INTERNATIONAL GROUP HOLDINGS LTD | 0.05% |
| QUANTUMPHARM INC | 0.40% |
| SHANGHAI MICROPORT MEDBOT GR | 1.44% |
| ABBISKO CAYMAN LTD | 0.12% |
| WUXI BIOLOGICS CAYMAN INC | 7.81% |
| WUXI APPTEC CO LTD | 8.00% |
| TYK MEDICINES-B ORD H | 0.08% |
| QYUNS-B ORD H | 0.05% |
| SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H | 0.50% |
| CSTONE PHARMACEUTICALS | 0.15% |
| SHANGHAI HENLIUS BIOTECH INC | 0.15% |
| CHINA RESOURCES PHARMACEUTICAL | 2.06% |
| HANSOH PHARMACEUTICAL GROUP CO | 8.00% |
| PHARMARON BEIJING CO LTD-H | 0.50% |
| SHANDONG BOAN BIOTECHNOLOGY CO LTD | 0.11% |
| SKB BIO-B ORD H | 4.38% |
| ZAI LAB LTD | 0.33% |
| AKESO INC | 8.00% |
| ALPHAMAB ONCOLOGY | 0.09% |
| REMEGEN CO LTD-H | 2.84% |
| KANGJI MEDICAL HOLDINGS LTD | 0.11% |